Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CYTH1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CNTN2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
LOC401317 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
DIP2B - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
SLC12A2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
VEZF1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
SLC44A1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
CFL2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
LAMP2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
C21orf91 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
GNAI1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
PREX1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
TGFA - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
DOCK5 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
ERMN - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
TMCC3 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
RAPGEF5 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
AMOTL2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
CCNE2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on